Jackson Square Capital’s Boston Scientific BSX Stock Holding History

Jackson Square Capital’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.41M	Buy	+55,164	New	+$2.55M	0.36%	51
2025 Q4	–	Sell	-7,272	Closed	-$710K	–	155
2025 Q3	$710K	Sell	7,272 -49,034	-87%	-$5.08M	0.15%	89
2025 Q2	$6.05M	Buy	+56,306	New	+$5.7M	1.34%	25
2023 Q4	–	Sell	-10,867	Closed	-$574K	–	119
2023 Q3	$574K	Buy	10,867 +2,052	+23%	+$108K	0.23%	71
2023 Q2	$477K	Buy	8,815 +4,538	+106%	+$237K	0.19%	87
2023 Q1	$214K	Buy	+4,277	New	+$202K	0.1%	102
2021 Q4	–	Sell	-12,041	Closed	-$522K	–	189
2021 Q3	$522K	Buy	12,041 +3,492	+41%	+$154K	0.17%	110
2021 Q2	$366K	Buy	+8,549	New	+$360K	0.12%	140
2020 Q4	–	Sell	-316	Closed	-$12K	–	174
2020 Q3	$12K	Hold	316	–	–	0.01%	254
2020 Q2	$11K	Buy	+316	New	+$11.4K	0.01%	237
2020 Q1	–	Sell	-33,983	Closed	-$1.54M	–	326
2019 Q4	$1.54M	Buy	+33,983	New	+$1.42M	0.89%	40

Other funds holding BSX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

ZWJ Investment Counsel Atlanta, Georgia $3.24B AUM 31.6% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Gradient Investments Arden Hills, Minnesota $7B AUM 14.85% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Fisher Funds Management Auckland, New Zealand $3.44B AUM 17.27% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Jackson Square Capital's BSX Position: Q3 2026 in Review

Jackson Square Capital opened a new position in Boston Scientific (BSX) in Q3 2026: 55,164 shares worth $2.41M. The stake represents 0.36% of the portfolio and ranks #51 among its holdings. This is a return to the name: Jackson Square Capital previously reported a position in BSX as recently as Q3 2025.

Jackson Square Capital first reported a position in BSX in Q4 2019 and has held it in 11 quarters since. The position peaked at $6.05M in Q2 2025. 267 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

Jackson Square Capital held 55,164 shares of Boston Scientific worth $2.41M as of Q3 2026.
Boston Scientific was a new Jackson Square Capital position in Q3 2026.
Boston Scientific made up 0.36% of Jackson Square Capital's portfolio in Q3 2026, its #51 holding.
Jackson Square Capital first reported a position in Boston Scientific in Q4 2019 and has held it in 11 quarters since.
Jackson Square Capital's Boston Scientific position peaked at $6.05M in Q2 2025.
267 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Jackson Square Capital's 13F filing for Q3 2026, filed 19 Oct 2026.